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Background: Coronary Artery Disease in Saudis is
reaching epidemic levels. The extent of Coronary Ath-
ero-Thrombosis (CAT) is yet to be studied. We present
the design and preliminary results of IVUS project
intended for centres with IVUS capabilities in Saudi Ara-
bia. We aim at gathering clinical and quantitative IVUS
data.
Methods: 60 pts. IVUS studies at Prince Salman
Heart Center (PSHC), King Fahad Medical City reviewed.
40 of 105 runs analysed for Borderline Lesions 35 pts. Pre-
Runs (PR), 67 runs 25 pts. post stenting (PS). Initial anal-
ysis done at IVUS Core-Lab Odense University Hospital
Odense–Denmark, now available at PSHC. Each 1 mm
slice, had separate Luminal and External Elastic
Membrane (EEM) tracings, obtained 5 mm Proximal
and Distal to maximal Plaque Burden.
Results: 35 pts. (28 males, mean age 54 ± 18). 27 pts.
(77%) Diabetics. Forty IVUS borderline lesions runs
analysed.
12 pts. (34.29%) with recent ST Elevation Myocardial
Infarction (STEMI), 8 (22.86%) Non-STEMI (NSTEMI),
and 15 (42.85%) Unstable Angina (UA).
Non-Diabetics had larger Luminal, Vessel Diameters,
and Plaque Areas (P value: 0.048, 0.008 , 0.0088, 0.020),
Diabetics with NSTEMI had larger Plaque Areas and
Burden (P value: 0.0003, 0.0033). Vessels volumes non-
significantly different.
Conclusion: SAUDICAT, is the first national quanti-
tative IVUS study of CAT of Saudi pts. with ACS. Non
diabetics had larger vessels, diabetics with STEMI, and
NSTEMI had larger plaque areas and burdens.
We believe with the completion of this project, a Core-
Lab for IVUS studies can be established in Saudi Arabia
and the Middle East.
http://dx.doi:10.1016/j.jsha.2012.06.211
Impact of in-hospital recurrent ischemia event:
Findings from Gulf RACE-2
Abdullah Al-Saleh, Ahmed Hersi, Khalid Al-
Habib, A.A. Alsheikh-Ali, K. Sulaiman, H. Alfaleh
Background: Little in the literature is known about
the long term outcome of patients with acute coronary
syndrome (ACS) and in-hospital recurrent ischemic
event. Accordingly; our objectives were to determine
the baseline characteristics of patients, the predictors,
and the long term outcome of patients with recurrent
ischemia.
Methods: The population compromised 7930
enrolled in the second Gulf Registry of Acute Coronary
Events (Gulf RACE-2).
Results: Out of the 7930 ACS patients, 172 (2.2%) had
Re-MI during their hospital stay. Patients with Re-MI
were more likely to be older (mean age 59.12 ± 13.5 vs.
56.8 ± 12.4, P = 0.016), had significantly higher rate of
prior history of angina (48% vs. 38.2%, P = 0.006), and
hyperlipidemia (45.2% vs. 37.3%, P = 0.027) than patients
without Re-MI. On admission patients with Re-MI had
significantly higher HR, lower systolic BP, Killip class 4
and high GRACE risk score than those without Re-MI
(27.3% vs. 17.6%), (11% vs. 4.8%), (8.1% vs. 3.2%), and
(31.8% vs. 21.5%, P < 0.05 for all comparisons), respec-
tively. Patients with Re-MI had a higher rate of STEMI
on admission than patients without Re-MI (72.1% vs.
43.9%; P < 0.001). Re-MI patients were less likely to
receive Aspirin (94.8% vs. 98.5%, P = 0.002), beta blockers
(95.3% vs. 74.7%, P < 0.001), and Statin (87.2% vs. 94.9%,
P < 0.001) than patients without Re-MI. Coronary angio-
gram was less frequently performed on patients with
Re-MI than patients without Re-MI (30.8% vs. 32.5%,
P = 0.036). In hospital adverse events including HF, car-
diogenic shock, VT/VF were more frequent in the Re-
MI group than patients without Re-MI (44.2% vs.
12.4%), (25.6% vs. 5.3%), (7.6% vs. 2.7%; P < 0.001 for all
comparisons) respectively. In ACS patients with Re-MI
in-hospital, 30 days and 1 year were significantly higher
that patients without Re-MI (23.8% vs. 4.1%), (28.1% vs.
7.7%), and (31.6% vs. 12.1%; P < 0.001 for all comparisons),
respectively.
Conclusion: Recognizing patients at high risk of Re-
MI is important as modifying the risk factors, and manag-
ing the patient aggressively may reduce the incidence of
such events and the associated morbidity and mortality.
http://dx.doi:10.1016/j.jsha.2012.06.212
Social impact of Congenital Heart diseases in
Saudi families
Sulaiman S. Almesned, Abdulrahman A.
Almesned, Ali A. Al-Akhfash
Introduction: Chronic illness may result in a variety
of stressful outcomes, families of children with congenital
heart disease are not exception.
In Saudi Arabia, many public supporting groups for
families with chronically ill children like diabetics or can-
cer patients are active and giving a great deal of help but
unfortunately, non are available for families of children
with severe congenital heart disease.
Our study is an effort to put this issue in focus.
Objective: To evaluate the social impact on families
of patients with of congenital heart disease.
Design: Cross sectional survey.
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